Nature Reviews Cancer旨在为癌症研究人员提供最好的综述及评论论文。该刊致力于发布权威、易读的文章，还具有清晰易懂的图表。同时，该刊希望为作者、审稿人和读者提供无与伦比的服务，并最大化每篇论文的实用性和影响力。癌症研究的最终目标使消除这种常见且具有毁灭性的疾病。为了开发更有效的防御措施，我们需要知道引发肿瘤的原因。为了准确地诊断癌前病变和早期癌症，这就需要检测引发癌变最早的分子变化。我们需要知道哪些分子变化会影响肿瘤的生长速度和转移，以便确诊。具体到个人癌症治疗，我们需要了解癌细胞与正常细胞之间的差别，和癌细胞之间的差异。所有的这些都取决于基础和应用研究的相结合。Nature Reviews Cancer的目标是成为癌症研究人员的信息门户，以增强诊断、治疗和预防癌症的能力。 
期刊收录研究方向：基因组不稳定性，增长促进信号，生长抑制信号，肿瘤干细胞，细胞坏死，代谢，肿瘤微环境，转移，致癌与癌症防御，癌症诊断与预断，癌症治疗新方法，实验系统与方法，癌症相关疾病，癌症研究的伦理、法律和社会问题，癌症诊断和治疗的常规方法

Review
Commentary

Chief Editor: Sarah Seton-Rogers, PhD ORCID
Sarah received her PhD in Cell Biology from Harvard Medical School, where she researched signalling pathways implicated in migration and invasion of breast cancer cells with Joan Brugge. She then worked for two years as a medical writer at a medical communications agency, focusing predominantly on clinical research in hypertension and atherosclerosis. She joined Nature Reviews Cancer as an Associate Editor in April 2006, became a Senior Editor on the journal in November 2009 and then Chief Editor in May 2014. Sarah is especially interested in molecular and cellular cancer biology, and cancer origins, evolution and heterogeneity.
Senior Editor: Anna Dart, PhD ORCID
Anna received her PhD in Cell Biology from Imperial College London where she researched signalling pathways involved in phagocytosis in the laboratory of Emmanuelle Caron. She continued her research work as a postdoc in Claire Wells’ laboratory at King’s College London investigating how PAK4 kinase and the Rho GTPase RhoU contribute to breast cancer cell migration. Anna moved into science publishing to expand her knowledge of all aspects of cancer. She joined Nature Reviews Cancer as an Associate Editor in May 2016 and became a Senior Editor on the journal in December 2018. Anna is especially interested in metastasis, the tumour microenvironment, and cancer genetics and epigenetics.
Senior Editor: Ulrike Harjes, PhD ORCID
Ulrike received her PhD in Medical Oncology from University of Oxford where she researched Notch signalling in endothelial cell metabolism and tumour angiogenesis with Adrian Harris and Barbara Fielding. She then worked as a postdoc in Peter Carmeliet’s laboratory at KU Leuven researching vascular metabolism in the context of cancer and diabetes. She joined Nature Reviews Cancer as an Associate Editor in July 2017 and became a Senior Editor on the journal in August 2019. Ulrike is especially interested in cancer metabolism, and cancer immunology and immunotherapy.
The editors of Nature Reviews Cancer are all based in the London, UK office.